Medline Inc. (MDLN) EV/Sales Ratio: 1.39x
Is Medline Inc.’s EV/Sales ratio high or low?
Medline Inc.'s EV/Sales ratio of 1.39x is 13% below its 1-year average of 1.60x, near the low end of its 1-year range (1.29x–1.87x).
As of Thursday, June 11, 2026. 13.11% below its 12-month average of 1.60x.
MDLN EV/Sales Ratio Chart
MDLN Average EV/Sales Ratio Chart
MDLN Current vs Average EV/Sales Ratio Chart
MDLN EV/Sales Ratio Metrics
EV/SALES RATIO
1.39x
EV/SALES RATIO AVG TTM
1.60x
EV/SALES RATIO AVG 3Y
1.60x
EV/SALES RATIO AVG 5Y
1.60x
EV/SALES RATIO AVG 10Y
1.60x
EV/SALES RATIO AVG 15Y
1.60x
EV/SALES RATIO AVG 20Y
1.60x
CURRENT VS TTM AVG
-13.11%
CURRENT VS 3Y AVG
-13.11%
CURRENT VS 5Y AVG
-13.11%
CURRENT VS 10Y AVG
-13.11%
CURRENT VS 15Y AVG
-13.11%
CURRENT VS 20Y AVG
-13.11%
MDLN Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $30.90B | 1.39x | 1.60x | 1.60x | 1.60x |
| IQVIA Holdings Inc. (IQV) | $30.08B | 1.85x | 2.83x | 3.22x | 3.53x |
| Centene Corporation (CNC) | $32.26B | 0.14x | 0.11x | 0.20x | 0.29x |
| Biogen Inc. (BIIB) | $28.94B | 3.26x | 2.79x | 3.30x | 3.58x |
| DexCom, Inc. (DXCM) | $28.92B | 6.18x | 6.63x | 10.22x | 13.87x |
| Zoetis Inc. (ZTS) | $34.27B | 4.40x | 6.71x | 8.77x | 9.90x |
| Veeva Systems Inc. (VEEV) | $26.31B | 7.65x | 12.50x | 13.33x | 15.70x |
| Agilent Technologies, Inc. (A) | $36.21B | 5.38x | 5.56x | 5.75x | 6.21x |
| Waters Corporation (WAT) | $23.21B | 9.27x | 7.03x | 7.13x | 7.32x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 6.13x | 7.35x | 7.51x | 8.18x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Medline Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medline Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Medline Inc. (MDLN)?
- The EV/Sales ratio for MDLN stock is 1.39x.
- Is Medline Inc.'s EV/Sales ratio high or low?
- Medline Inc.'s EV/Sales ratio of 1.39x is 13% below its 1-year average of 1.60x, near the low end of its 1-year range (1.29x–1.87x).
- What is the TTM average EV/Sales ratio for Medline Inc. (MDLN)?
- The TTM average EV/Sales ratio for MDLN stock is 1.60x.
- What is the 3Y average EV/Sales ratio for Medline Inc. (MDLN)?
- The 3Y average EV/Sales ratio for MDLN stock is 1.60x.
- What is the 5Y average EV/Sales ratio for Medline Inc. (MDLN)?
- The 5Y average EV/Sales ratio for MDLN stock is 1.60x.
- What is the 10Y average EV/Sales ratio for Medline Inc. (MDLN)?
- The 10Y average EV/Sales ratio for MDLN stock is 1.60x.
- What is the 15Y average EV/Sales ratio for Medline Inc. (MDLN)?
- The 15Y average EV/Sales ratio for MDLN stock is 1.60x.
- What is the 20Y average EV/Sales ratio for Medline Inc. (MDLN)?
- The 20Y average EV/Sales ratio for MDLN stock is 1.60x.
Medline Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-10 | 1.39x |
| 2026-06-09 | 1.37x |
| 2026-06-08 | 1.31x |
| 2026-06-05 | 1.31x |
| 2026-06-04 | 1.33x |
| 2026-06-03 | 1.33x |
| 2026-06-02 | 1.29x |
| 2026-06-01 | 1.37x |
| 2026-05-29 | 1.39x |
| 2026-05-28 | 1.40x |
| 2026-05-27 | 1.37x |
| 2026-05-26 | 1.38x |
| 2026-05-22 | 1.40x |
| 2026-05-21 | 1.41x |
| 2026-05-20 | 1.38x |
| 2026-05-19 | 1.42x |
| 2026-05-18 | 1.37x |
| 2026-05-15 | 1.38x |
| 2026-05-14 | 1.46x |
| 2026-05-13 | 1.45x |
| 2026-05-12 | 1.45x |
| 2026-05-11 | 1.47x |
| 2026-05-08 | 1.47x |
| 2026-05-07 | 1.54x |
| 2026-05-06 | 1.54x |
| 2026-05-05 | 1.64x |
| 2026-05-04 | 1.61x |
| 2026-05-01 | 1.62x |
| 2026-04-30 | 1.61x |
| 2026-04-29 | 1.58x |
| 2026-04-28 | 1.61x |
| 2026-04-27 | 1.64x |
| 2026-04-24 | 1.62x |
| 2026-04-23 | 1.66x |
| 2026-04-22 | 1.69x |
| 2026-04-21 | 1.70x |
| 2026-04-20 | 1.72x |
| 2026-04-17 | 1.70x |
| 2026-04-16 | 1.68x |
| 2026-04-15 | 1.71x |
| 2026-04-14 | 1.70x |
| 2026-04-13 | 1.69x |
| 2026-04-10 | 1.65x |
| 2026-04-09 | 1.65x |
| 2026-04-08 | 1.61x |
| 2026-04-07 | 1.58x |
| 2026-04-06 | 1.60x |
| 2026-04-02 | 1.61x |
| 2026-04-01 | 1.60x |
| 2026-03-31 | 1.61x |
| 2026-03-30 | 1.56x |
| 2026-03-27 | 1.55x |
| 2026-03-26 | 1.58x |
| 2026-03-25 | 1.59x |
| 2026-03-24 | 1.57x |
| 2026-03-23 | 1.59x |
| 2026-03-20 | 1.59x |
| 2026-03-19 | 1.62x |
| 2026-03-18 | 1.58x |
| 2026-03-17 | 1.58x |
| 2026-03-16 | 1.57x |
| 2026-03-13 | 1.56x |
| 2026-03-12 | 1.55x |
| 2026-03-11 | 1.58x |
| 2026-03-10 | 1.60x |
| 2026-03-09 | 1.61x |
| 2026-03-06 | 1.63x |
| 2026-03-05 | 1.63x |
| 2026-03-04 | 1.60x |
| 2026-03-03 | 1.64x |
| 2026-03-02 | 1.68x |
| 2026-02-27 | 1.73x |
| 2026-02-26 | 1.77x |
| 2026-02-25 | 1.75x |
| 2026-02-24 | 1.80x |
| 2026-02-23 | 1.79x |
| 2026-02-20 | 1.80x |
| 2026-02-19 | 1.73x |
| 2026-02-18 | 1.74x |
| 2026-02-17 | 1.69x |
| 2026-02-13 | 1.65x |
| 2026-02-12 | 1.65x |
| 2026-02-11 | 1.66x |
| 2026-02-10 | 1.67x |
| 2026-02-09 | 1.73x |
| 2026-02-06 | 1.72x |
| 2026-02-05 | 1.69x |
| 2026-02-04 | 1.66x |
| 2026-02-03 | 1.65x |
| 2026-02-02 | 1.66x |
| 2026-01-30 | 1.64x |
| 2026-01-29 | 1.62x |
| 2026-01-28 | 1.64x |
| 2026-01-27 | 1.70x |
| 2026-01-26 | 1.65x |
| 2026-01-23 | 1.69x |
| 2026-01-22 | 1.69x |
| 2026-01-21 | 1.61x |
| 2026-01-20 | 1.63x |
| 2026-01-16 | 1.63x |
| 2026-01-15 | 1.59x |
| 2026-01-14 | 1.61x |
| 2026-01-13 | 1.60x |
| 2026-01-12 | 1.59x |
| 2026-01-09 | 1.53x |
| 2026-01-08 | 1.55x |
| 2026-01-07 | 1.53x |
| 2026-01-06 | 1.51x |
| 2026-01-05 | 1.49x |
| 2026-01-02 | 1.53x |
| 2025-12-31 | 1.57x |
| 2025-12-30 | 1.80x |
| 2025-12-29 | 1.80x |
| 2025-12-26 | 1.87x |
| 2025-12-24 | 1.87x |
| 2025-12-23 | 1.85x |
| 2025-12-22 | 1.81x |
| 2025-12-19 | 1.79x |
| 2025-12-18 | 1.73x |
| 2025-12-17 | 1.77x |
Related Metrics
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- James Boyle